Sovesudil

Overview

Sovesudil (PHP-201) is a potent, ATP-competitive, locally acting Rho kinase ( ROCK ) inhibitor with IC 50 s of 3.7 and 2.3 nM for ROCK-I and ROCK-II, respectively. Sovesudil lowers intraocular pressure (IOP) without inducing hyperemia.

Application

Products | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Others | Products > Signaling Pathways > ROCK

Product Information

• Catalog No.: HY-109191
• CAS No.: 1333400-14-8
• Molecular Formula: C23H22FN3O3
• Molecular Weight: 407.44
• Purity: 99.91%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.14 mM); Clear solution
• Availability: In-stock

Source

Original product source